FDA Inspection
Similasan AGSimilasan AG – FDA Inspection, Apr 4, 2023
Record Details
This FDA Inspection record concerns Similasan AG, with an inspection on April 4, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d03916c3-5fac-4fb3-a45e-302e5b3ce40f
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1204144
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- Warning Letter
Other FDA inspections of Similasan AG
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 27, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| September 18, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 23, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 13, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 27, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Similasan AG
- FDA Inspection 1313406 - 2026-04-27
- FDA Inspection 1028938 - 2017-09-18
- FDA Inspection 937801 - 2015-07-23
- FDA Inspection 851899 - 2013-09-13
- FDA Inspection 727380 - 2011-05-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.